Literature DB >> 387819

Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids.

W F Stenson, C W Parker.   

Abstract

[14C]Arachidonic acid incubated with human neutrophils was esterified into phospholipids and triglycerides. Stimulation of these labeled neutrophils with ionophore A23187 (2 microM) results in release of [14C]arachidonate from phospholipid and its metabolism to prostaglandin E2 and 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE), a lipoxygenase product. The released arachidonate is also metabolized to a polar lipid of unknown composition here disignated compound A. 5-HETE was found to be released into the medium and then taken up again by the cells. To determine its metabolic fate, [14C]5-HETE was prepared biosynthetically, purified, and incubated with stimulated, unlabeled neutrophils. Most of the radioactivity entered the cells and was esterified into phospholipids and triglycerides. The radiolabeled complex lipids were saponified, and the released fatty acids cochromatographed with authentic 5-HETE. The esterification of 5-HETE, a hydroxylated fatty acid, into membrane phospholipids may be an example of a more generalized mechanism for altering membrane characteristics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387819      PMCID: PMC371295          DOI: 10.1172/JCI109604

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Ionophore A-23187- and thrombin-induced platelet aggregation: independence from cycloxygenase products.

Authors:  E G Lapetina; K A Chandrabose; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  Prostaglandin release from human polymorphonuclear leukocytes.

Authors:  R B Zurier
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1976

3.  Stimulation of the release of prostaglandins from polymorphonuclear leukocytes by the calcium inophore A23187.

Authors:  B Wentzell; R M Epand
Journal:  FEBS Lett       Date:  1978-02-15       Impact factor: 4.124

4.  Release of slow reacting substance (SRS) from rat basophilic leukemia (RBL-1) cells.

Authors:  B A Jakschik; A Kulczycki; H H MacDonald; C W Parker
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

5.  Chronic granulomatous disease in females.

Authors:  B Holmes; B H Park; S E Malawista; P G Quie; D L Nelson; R A Good
Journal:  N Engl J Med       Date:  1970-07-30       Impact factor: 91.245

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.

Authors:  P Borgeat; M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

8.  The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes.

Authors:  J Mendelsohn; A Skinner; S Kornfeld
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

9.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

10.  Thromboxane generation by human peripheral blood polymorphonuclear leukocytes.

Authors:  I M Goldstein; C L Malmsten; H Kindahl; H B Kaplan; O Rådmark; B Samuelsson; G Weissmann
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

View more
  51 in total

Review 1.  Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.

Authors:  A G Rossi; J T O'Flaherty
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 2.  Molecular mechanisms of calcium-induced membrane fusion.

Authors:  D Papahadjopoulos; S Nir; N Düzgünes
Journal:  J Bioenerg Biomembr       Date:  1990-04       Impact factor: 2.945

3.  Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.

Authors:  J K Beckman; J C Gay; A R Brash; J N Lukens; J A Oates
Journal:  Lipids       Date:  1985-06       Impact factor: 1.880

4.  Inhibitory effects of methyl 7-butyl-4,5,6,7-tetrahydro-3-methylamino-4,6-dioxo-5-propyl- 2H-pyrazolo[3,4-d]pyrimidine-2-carboxylate (AA-2379) on lysosomal enzyme and arachidonic acid release from rat polymorphonuclear leukocytes and its mode of action.

Authors:  H Makino; T Saijo; Y Maki
Journal:  Agents Actions       Date:  1989-11

5.  Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

Authors:  W F Stenson; E Lobos
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids.

Authors:  J T O'Flaherty; M J Thomas; C J Lees; C E McCall
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

7.  Antiinflammatory properties of a hydroperoxide compound, structurally related to acetylsalicylic acid.

Authors:  J J Killackey; B A Killackey; I Cerskus; R B Philp
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

8.  Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.

Authors:  P A Ward; M C Sulavik; K J Johnson
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

9.  Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin.

Authors:  B Grøn; L Iversen; V Ziboh; K Kragballe
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis.

Authors:  L S Mayorga; M I Colombo; M Lennartz; E J Brown; K H Rahman; R Weiss; P J Lennon; P D Stahl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.